Ranbaxy Laboratories Ltd has informed BSE regarding a Press Release dated November 05, 2014 titled 'Ranbaxy receives approval from US FDA to market Fenofibrate Capsules USP, 43 MG and 130 MG'.
Ask Value Research 
News Announcement
Ranbaxy Laboratories: Ranbaxy receives approval from US FDA to market Fenofibrate Capsules USP, 43 MG and 130 MG
05-Nov-2014
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
